Searched for
ASTRAZENECA INDIA SHARES
Scanning cancer, up close & personal: A revolution is underway in cancer diagnosisA gene-based test called next-generation sequencing can identify precise mutations, which can then be treated with targeted therapies. Sinc...- AstraZeneca's Enhertu gets regulatory approval in India for first-line HER2-positive breast cancerAstraZeneca Pharma India has secured approval from India's drug regulator for its smart chemotherapy drug Enhertu. This allows for its impo...
- Ahead of Market: 10 things that will decide stock market action on MondayIndian stock markets experienced sharp cuts on Thursday, with Nifty and Sensex declining due to rising oil prices and a falling rupee. Sell...
- AstraZeneca Pharma India shares surge over 3% on new Hyperkalaemia drug deal with Sun PharmaOn Tuesday, shares of AstraZeneca Pharma India surged following the announcement of an exciting alliance with Sun Pharmaceutical Industries...
- AstraZeneca India Q1 results: Net profit declines 45% to Rs 10 crRevenue from operations stood at Rs 175.40 crore for the quarter under consideration. It was Rs 193.57 crore for the same period a year ago...
- AstraZeneca Pharma surges 10% as WHO gives nod to Covid vaccine for emergency useThe WHO said on Monday that it was clearing the AstraZeneca vaccines made by the Serum Institute of India and South Korea's AstraZeneca-SKB...
- AstraZeneca Pharma gets DCGI nod to market asthma drugAstraZeneca Pharma said the receipt of this permission paves way for the launch of Benralizumab (Fasenra) in India, subject to the receipt ...
- AstraZeneca Pharma India gets DCGI nod to market diabetes drugThe product is indicated as an adjunct therapy to diet and exercise to improve glycemic control in adults with type 2 diabetes, AstraZeneca...
- AstraZeneca Pharma India appoints Gagan Singh Bedi as MDThe company has accepted resignation of Sanjay Murdeshwar as MD and as a director. He is shifting to a global role within the AstraZeneca g...
- Pfizer surges 7% on acquisition of Neksium brand from AstraZenecaFollowing the announcement, the scrip rose 7.15 pr cent to hit a high of Rs 1,785.80 on BSE.
- AstraZeneca Pharma India to close Bengaluru API unitDrug firm AstraZeneca Pharma India will close its Active Pharmaceutical Ingredient (API) unit at Bengaluru due to low demand for the produc...
- AstraZeneca Pharma board approves delisting of company's shares from stock exchangesAstraZeneca Pharma today said its board has approved delisting of the company's shares from bourses, including BSE and the National Stock E...
- AstraZeneca Pharma shares rise 3 per cent on board's approved delisitngShares of AstraZeneca Pharma rose by 3 per cent as its board has approved delisting of the company's shares from bourses like NSE, BSE etc.
- Astrazeneca stock down over 9% as board defers delisting offerAstrazeneca Pharma's scrip ended the day 9.31 per cent lower at Rs 1,064.35 on the BSE. During the day, the stock tanked 9.85 per cent to R...
- AstraZeneca up 20% on delisting proposal, locked in upper circuit at Rs 1,110.90AstraZeneca said in the filing before markets opened on Monday that its board received a request from its promoter to initiate a voluntary ...
- Buy AstraZeneca Pharma India Ltd with a target of Rs 870: Ashwani Gujral"AstraZeneca Pharma India Ltd is a ‘BUY’ call with a target of Rs 870 and a stop loss of Rs 825."
- AstraZeneca Pharma promoter to sell stake in Indian armAstraZeneca India today said its promoter AstraZeneca Pharmaceuticals AB Sweden plans to offload around 37 lakh shares through offer for sa...
- AstraZeneca Q4 net loss at Rs 33 crAstraZeneca Pharma India today reported a net loss of Rs 33 crore for the quarter ended March 31, 2012, due to a voluntary recall of steril...
- 25pc public holding norm has AstraZeneca, Sulzer delistingThe domestic arms of two multinational companies, the drug maker AstraZeneca and process engineering major Sulzer, plan to delist from the ...
- AstraZeneca Pharma to delist from India; shares jump 20 pcAstraZeneca Pharma India today said it will de-list itself from domestic stock exchanges, fueling a jump of 20 per cent in its stock price ...
Load More
